Any feedback?
Please rate this page
(search_result.php)
(0/150)

BRENDA support

Refine search

Search Disease/ Diagnostics

show results
Refine your search

Search term:

Results 1 - 10 of 241 > >>
EC Number Disease PubMed ID Title of Publication Category Confidence Level
Show all pathways known for 1.14.14.19Display the word mapDisplay the reaction diagram Show all sequences 1.14.14.1917alpha-hydroxyprogesterone deacetylase deficiency 9177409 A 5'-splice site mutation in the cytochrome P450 steroid 17alpha-hydroxylase gene in 17alpha-hydroxylase deficiency. causal interaction
unassigned
4
0
Show all pathways known for 1.14.14.19Display the word mapDisplay the reaction diagram Show all sequences 1.14.14.1917alpha-hydroxyprogesterone deacetylase deficiency 11549876 New compound heterozygous mutation in the CYP17 gene in a 46,XY girl with 17 alpha-hydroxylase/17,20-lyase deficiency. causal interaction
diagnostic usage
ongoing research
unassigned
4
4
3
0
Show all pathways known for 1.14.14.19Display the word mapDisplay the reaction diagram Show all sequences 1.14.14.1917alpha-hydroxyprogesterone deacetylase deficiency 12466376 Differential inhibition of 17alpha-hydroxylase and 17,20-lyase activities by three novel missense CYP17 mutations identified in patients with P450c17 deficiency. causal interaction
diagnostic usage
therapeutic application
unassigned
4
2
1
0
Show all pathways known for 1.14.14.19Display the word mapDisplay the reaction diagram Show all sequences 1.14.14.1917alpha-hydroxyprogesterone deacetylase deficiency 12706306 A complex heterozygous mutation of His373Leu and Asp487-Ser488-Phe489 deletion in human cytochrome P450c17 causes 17alpha-hydroxylase/17,20-lyase deficiency in three Chinese sisters. causal interaction
ongoing research
unassigned
4
1
0
Show all pathways known for 1.14.14.19Display the word mapDisplay the reaction diagram Show all sequences 1.14.14.1917alpha-hydroxyprogesterone deacetylase deficiency 14504283 CYP17 mutation E305G causes isolated 17,20-lyase deficiency by selectively altering substrate binding. causal interaction
unassigned
3
0
Show all pathways known for 1.14.14.19Display the word mapDisplay the reaction diagram Show all sequences 1.14.14.1917alpha-hydroxyprogesterone deacetylase deficiency 19793597 Novel CYP17A1 mutation in a Japanese patient with combined 17alpha-hydroxylase/17,20-lyase deficiency. causal interaction
diagnostic usage
ongoing research
unassigned
4
4
3
0
Show all pathways known for 1.14.14.19Display the word mapDisplay the reaction diagram Show all sequences 1.14.14.1917alpha-hydroxyprogesterone deacetylase deficiency 21340176 Distinctive profile of the 17-hydroxylase and 17,20-lyase activities revealed by urinary steroid metabolomes of patients with CYP17 deficiency. causal interaction
diagnostic usage
unassigned
3
1
0
Show all pathways known for 1.14.14.19Display the word mapDisplay the reaction diagram Show all sequences 1.14.14.19Addison Disease 29982238 Three new Brazilian cases of 17?-hydroxylase deficiency: clinical, molecular, hormonal, and treatment features. causal interaction
diagnostic usage
therapeutic application
unassigned
3
2
1
0
Show all pathways known for 1.14.14.19Display the word mapDisplay the reaction diagram Show all sequences 1.14.14.19Adenoma 8137519 In-vitro evidence for the regulation of 17,20-lyase activity by cytochrome b5 in adrenocortical adenomas from patients with Cushing's syndrome. causal interaction
diagnostic usage
ongoing research
therapeutic application
4
1
3
1
Show all pathways known for 1.14.14.19Display the word mapDisplay the reaction diagram Show all sequences 1.14.14.19Adenoma 8288710 Mechanism of abnormal production of adrenal androgens in patients with adrenocortical adenomas and carcinomas. causal interaction
diagnostic usage
ongoing research
therapeutic application
4
4
2
1
Results 1 - 10 of 241 > >>